Effect of baseline body mass index (BMI; < 30 kg/m2, ≥30-< 35 kg/m2, and ≥35 kg/m2) on glycaemic response and weight change in patients with type 2 diabetes (T2DM) with baseline HbA1c ≥7.5% after treatment with the once-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA), dulaglutide, and active comparators in five clinical studies (AWARD 1 – 5)

2015 ◽  
Vol 10 (S 01) ◽  
Author(s):  
M Cummings ◽  
R Gentilella ◽  
C Nicolay ◽  
O Adetunji
Keyword(s):  
Type 2 Diabetes ◽  
Body Mass Index ◽  
Clinical Studies ◽  
Receptor Agonist ◽  
Baseline Body Mass Index ◽  
Baseline Hba1c ◽  
Glycaemic Response ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1
Sign in / Sign up

Export Citation Format

Share Document